NYTRICX INC
Athens, GA · Medtech · Private
Nitric oxide-releasing and liquid-infused urinary catheters with antimicrobial coatings to prevent infections.
nytricx.com →- Grants
- $4.5M
- 9 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓202320242025
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Nitric oxide Releasing Ultra-Slippery Antibacterial Surfaces for Urological Catheter Applications | $337,395 | |
| Federal grant | Department of Health and Human Services · Phase I · Nitric oxide Releasing Ultra-Slippery Antibacterial Surfaces for Urological Catheter Applications | $337,395 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase II · Ultra-low Fouling and Anti-infective and Anti-thrombotic Nitric Oxide Releasing Intravascular Catheters | $1,193,055 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase II · Ultra-low Fouling and Anti-infective and Anti-thrombotic Nitric Oxide Releasing Intravascular Catheters | $1,193,055 | |
| Federal grant | Department of Health and Human Services · Phase II · Ultra-low Fouling and Anti-infective and Anti-thrombotic Nitric Oxide Releasing Intravascular Catheters | $106,358 | |
| Federal grant | Department of Health and Human Services · Phase II · Ultra-low Fouling and Anti-infective and Anti-thrombotic Nitric Oxide Releasing Intravascular Catheters | $50,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Ultra-low Fouling and Anti-infective and Anti-thrombotic Nitric Oxide Releasing Intravascular Catheters | $875,855 | |
| Federal grant | Department of Health and Human Services · Phase II · Ultra-low Fouling and Anti-infective and Anti-thrombotic Nitric Oxide Releasing Intravascular Catheters | $121,338 | |
| Federal grant | Department of Health and Human Services · Phase I · Enhanced Prosthetic Vascular Graft Function by Local Release of Nitric Oxide | $311,824 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1962 | TRANZ BIOSCIENCES, LLC | — | — |
| 1963 | GAiTE LLC | — | — |
| 1964 | CHARLES RIVER ANALYTICS, INC. | — | — |
| 1965 | NYTRICX INC | — | — |
| 1966 | MICROBIOCHIP DIAGNOSTICS LLC | — | — |
| 1967 | LXS, LLC | — | — |
| 1968 | PNEUMICO, LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.